Clinical Trial Update: Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine with cisplatin versus gemcitabine with carboplatin in non-small cell lung cancer reports hospitalization rates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Cisplatin (Platinol) (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Lung Cancer | Phase 3 | Status: UNKNOWN